Literature DB >> 20106921

Comparison of the biological and biochemical activities of several members of the alphaherpesvirus ICP0 family of proteins.

Roger D Everett1, Chris Boutell, Carol McNair, Louise Grant, Anne Orr.   

Abstract

Immediate-early protein ICP0 of herpes simplex virus type 1 (HSV-1) is an E3 ubiquitin ligase of the RING finger class that is required for efficient lytic infection and reactivation from latency. Other alphaherpesviruses also express ICP0-related RING finger proteins, but these have limited homology outside the core RING domain. Existing evidence indicates that ICP0 family members have similar properties, but there has been no systematic comparison of the biochemical activities and biological functions of these proteins. Here, we describe an inducible cell line system that allows expression of the ICP0-related proteins of bovine herpes virus type 1 (BHV-1), equine herpesvirus type 1 (EHV-1), pseudorabies virus (PRV), and varicella-zoster virus (VZV) and their subsequent functional analysis. We report that the RING domains of all the proteins have E3 ubiquitin ligase activity in vitro. The BHV-1, EHV-1, and PRV proteins complement ICP0-null mutant HSV-1 plaque formation and induce derepression of quiescent HSV-1 genomes to levels similar to those achieved by ICP0 itself. VICP0, the ICP0 expressed by VZV, was found to be extremely unstable, which limited its analysis in this system. We compared the abilities of the ICP0-related proteins to disrupt ND10, to induce degradation of PML and Sp100, to affect key components of the interferon signaling pathway, and to interfere with induction of interferon-stimulated genes. We found that the property that correlated most closely with their biological activities was the ability to preclude the recruitment of cellular ND10 proteins to sites closely associated with incoming HSV-1 genomes and early replication compartments.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20106921      PMCID: PMC2838103          DOI: 10.1128/JVI.02544-09

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  78 in total

1.  Evidence that the herpes simplex virus type 1 ICP0 protein does not initiate reactivation from latency in vivo.

Authors:  R L Thompson; N M Sawtell
Journal:  J Virol       Date:  2006-08-30       Impact factor: 5.103

2.  The infected cell protein 0 encoded by bovine herpesvirus 1 (bICP0) induces degradation of interferon response factor 3 and, consequently, inhibits beta interferon promoter activity.

Authors:  Kazima Saira; You Zhou; Clinton Jones
Journal:  J Virol       Date:  2007-01-10       Impact factor: 5.103

3.  Differential role of Sp100 isoforms in interferon-mediated repression of herpes simplex virus type 1 immediate-early protein expression.

Authors:  Dmitri G Negorev; Olga V Vladimirova; Alexey Ivanov; Frank Rauscher; Gerd G Maul
Journal:  J Virol       Date:  2006-08       Impact factor: 5.103

4.  Suppression of the interferon-mediated innate immune response by pseudorabies virus.

Authors:  Alla Brukman; L W Enquist
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

5.  Pseudorabies virus EP0 protein counteracts an interferon-induced antiviral state in a species-specific manner.

Authors:  Alla Brukman; L W Enquist
Journal:  J Virol       Date:  2006-08-23       Impact factor: 5.103

6.  STAT-1- and IRF-3-dependent pathways are not essential for repression of ICP0-null mutant herpes simplex virus type 1 in human fibroblasts.

Authors:  Roger D Everett; Dan F Young; Rick E Randall; Anne Orr
Journal:  J Virol       Date:  2008-06-25       Impact factor: 5.103

7.  Herpes simplex virus type 1 genomes are associated with ND10 nuclear substructures in quiescently infected human fibroblasts.

Authors:  Roger D Everett; Jill Murray; Anne Orr; Chris M Preston
Journal:  J Virol       Date:  2007-08-01       Impact factor: 5.103

8.  PML contributes to a cellular mechanism of repression of herpes simplex virus type 1 infection that is inactivated by ICP0.

Authors:  Roger D Everett; Sabine Rechter; Peer Papior; Nina Tavalai; Thomas Stamminger; Anne Orr
Journal:  J Virol       Date:  2006-08       Impact factor: 5.103

9.  ICP0 antagonizes Stat 1-dependent repression of herpes simplex virus: implications for the regulation of viral latency.

Authors:  William P Halford; Carla Weisend; Jennifer Grace; Mark Soboleski; Daniel J J Carr; John W Balliet; Yumi Imai; Todd P Margolis; Bryan M Gebhardt
Journal:  Virol J       Date:  2006-06-09       Impact factor: 4.099

10.  Replication of ICP0-null mutant herpes simplex virus type 1 is restricted by both PML and Sp100.

Authors:  Roger D Everett; Carlos Parada; Philippe Gripon; Hüseyin Sirma; Anne Orr
Journal:  J Virol       Date:  2007-12-26       Impact factor: 5.103

View more
  50 in total

1.  CRM1-dependent transport supports cytoplasmic accumulation of adenoviral early transcripts.

Authors:  Melanie Schmid; Ramon A Gonzalez; Thomas Dobner
Journal:  J Virol       Date:  2011-12-14       Impact factor: 5.103

2.  High-yield expression in Escherichia coli and purification of mouse ubiquitin-activating enzyme E1.

Authors:  Andreia F Carvalho; Manuel P Pinto; Cláudia P Grou; Rui Vitorino; Pedro Domingues; Fumiaki Yamao; Clara Sá-Miranda; Jorge E Azevedo
Journal:  Mol Biotechnol       Date:  2012-07       Impact factor: 2.695

3.  Herpes simplex viral-vector design for efficient transduction of nonneuronal cells without cytotoxicity.

Authors:  Yoshitaka Miyagawa; Pietro Marino; Gianluca Verlengia; Hiroaki Uchida; William F Goins; Shinichiro Yokota; David A Geller; Osamu Yoshida; Joseph Mester; Justus B Cohen; Joseph C Glorioso
Journal:  Proc Natl Acad Sci U S A       Date:  2015-03-16       Impact factor: 11.205

4.  Tuberous Sclerosis Complex Protein 2-Independent Activation of mTORC1 by Human Cytomegalovirus pUL38.

Authors:  Yadan Bai; Baoqin Xuan; Haiyan Liu; Jin Zhong; Dong Yu; Zhikang Qian
Journal:  J Virol       Date:  2015-05-13       Impact factor: 5.103

5.  SUMOylation Targets Adeno-associated Virus Capsids but Mainly Restricts Transduction by Cellular Mechanisms.

Authors:  Qingxin Chen; Robin Njenga; Barbara Leuchs; Susanna Chiocca; Jürgen Kleinschmidt; Martin Müller
Journal:  J Virol       Date:  2020-09-15       Impact factor: 5.103

6.  Evaluation of the effects of acyclovir and/or human amniotic membrane on herpes virus culture and quantitative virus inactivity by real-time polymerase chain reaction.

Authors:  Feride Aylin Kantarci; Ali Reza Faraji; Aykut Ozkul; Fikret Akata
Journal:  Int J Ophthalmol       Date:  2014-08-18       Impact factor: 1.779

7.  Swine Promyelocytic Leukemia Isoform II Inhibits Pseudorabies Virus Infection by Suppressing Viral Gene Transcription in Promyelocytic Leukemia Nuclear Bodies.

Authors:  Cuilian Yu; Aotian Xu; Yue Lang; Chao Qin; Mengdong Wang; Xiufang Yuan; Shengfu Sun; Wenhai Feng; Chao Gao; Jinwen Chen; Rui Zhang; Jun Tang
Journal:  J Virol       Date:  2020-08-31       Impact factor: 5.103

8.  The RING finger domain of Varicella-Zoster virus ORF61p has E3 ubiquitin ligase activity that is essential for efficient autoubiquitination and dispersion of Sp100-containing nuclear bodies.

Authors:  Matthew S Walters; Christos A Kyratsous; Saul J Silverstein
Journal:  J Virol       Date:  2010-04-14       Impact factor: 5.103

9.  ICP0 dismantles microtubule networks in herpes simplex virus-infected cells.

Authors:  Mingyu Liu; Edward E Schmidt; William P Halford
Journal:  PLoS One       Date:  2010-06-08       Impact factor: 3.240

10.  Identification of a hydrophobic domain in varicella-zoster virus ORF61 necessary for ORF61 self-interaction, viral replication, and skin pathogenesis.

Authors:  Li Wang; Jaya Rajamani; Marvin Sommer; Leigh Zerboni; Ann M Arvin
Journal:  J Virol       Date:  2013-01-23       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.